Search for: "Apotex Corporation" Results 81 - 100 of 135
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Feb 2011, 3:47 pm
Loser Microsoft (v. i4i) has that going for invalidity all the way to the Supreme Court, which always toadies to power, governmental or corporate. [read post]
18 Feb 2011, 11:47 am by Sheppard Mullin
., Bristol-Myers Squibb Company and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively “Sanofi”) and Apotex Corporation (“Apotex”). [read post]
4 Feb 2011, 2:28 pm by Dennis Crouch
Shashank Upadhye (Apotex's IP chief) generally presents interesting arguments. [read post]
3 Feb 2011, 2:11 pm by Bexis
A few weeks ago a regular reader, and occasional correspondent, Prof. [read post]
14 Jan 2011, 10:07 am by Christa Culver
Certiorari stage documents:Opinion below (Court of Appeals for the Federal Circuit)Petition for certiorariBrief in oppositionAmicus brief of the Federal Timber Purchasers Committee, et al.Petitioner's reply Title: Pella Corporation v. [read post]
12 Oct 2010, 8:56 pm by Kelly
Eisai Co (Orange Book Blog) (FDA Law Blog) (Patently-O) Azilect (Rasagiline) – US: Teva files patent infringement suits against Mylan and Watson in response to Para IV certification (Patent Docs) Boniva (Ibandronic acid) – US: Roche Boniva patent dispute with Apotex, Cobalt goes to jury (Patent Docs) Cozaar (Losartan) / Hyzaar (Losartan, Hydrochlorothiazide) – US: It lives!! [read post]
15 Sep 2010, 2:40 am by Kelly
(Afro-IP) Africa: Giving consumers power in the battle against counterfeits (Afro-IP) Australia: Review Four Corners’ ‘Body Corporate’ program on gene patenting (Patentology) India: Roche and Novartis, finally, manage to defend their patents in oppositions filed by Cipla (Spicy IP) South Africa: San people push for new legislation – demand protection for indigenous knowledge and IP including medicinal remedies derived from plants including Hoodia (Afro-IP) US:… [read post]
25 Apr 2010, 5:52 pm by FDABlog HPM
  The FTC charged that, among other things, BMS failed to disclose (as part of a patent settlement with Apotex) that the company orally promised that it would not compete with Apotex during the first 180-days that Apotex marketed its generic version of PLAVIX. [read post]
3 Feb 2010, 2:00 am
Barr Laboratories, Inc. and Mylan Pharma (Patent Docs) (Patently-O) Omnicef (Cefdinir) – US: CAFC on whether a product-by-process claim is infringed by an identical product made by different process: Abbott Labs v Sandoz (IP Frontline) Pertussis vaccines – UK: EWHC dismisses Medeva appeal against pertussis vaccines SPCs refusal (The SPC Blog) Plavix (Clopidogrel) – Canada: Adding some obvious flexibility: Apotex Inc v Sanofi-Synthelabo Canada Inc (IP Osgoode) Rapamune… [read post]
22 Dec 2009, 10:33 am by Pilar G. Kraman
Judge Stark noted that “Apotex Inc. is a Canadian corporation with a principal place of business in Canada. [read post]
30 Nov 2009, 12:00 am
– visual artists will eventually receive small share of resale value of their artworks (1709 Copyright Blog)   Canada Patents update – new Practice Notice on Obviousness 2 Nov 2009 – introduces four part test on obviousness following Apotex v Sanofi-Synthelabo (ipblog.ca) Court injects ‘duty of candour’ requirements for patent agents: Lundbeck Canada v Ratiopharm (Pharmacapsules @ Gowlings) Vancouver Olympic Committee unravels Cowichan sweater trade mark… [read post]
2 Nov 2009, 1:24 pm
  Robert Barnes writes in Sunday's Washington Post that the case could spur "years of judicial review of the measures that the Obama administration and Congress have taken" with regard to the current economic crisis; Barnes also points out that the abundance of business cases before the Court this term will pose an "interesting test" for Justice Sotomayor, given her background in corporate law. [read post]